← back to search

Kathi Zarnack

University of Würzburg · DE
Area of research
Molecular Biology · Cancer Research
Research interest
Research interests include RNA Research and Splicing, RNA modifications and cancer, RNA and protein synthesis mechanisms, and Cancer-related molecular mechanisms research.
h-index
37
citations
6,001
works
148
NIH funding
primary concept
email

Recent publications

An atlas of RNA-dependent proteins in cell division reveals the riboregulation of mitotic protein-protein interactions
Nature Communications 2025cited by 11position: middledoi
Rapid depletion and super-resolution microscopy reveal dual roles of SRSF5 in coordinating nuclear speckle–paraspeckle crosstalk during cellular stress
Nucleic Acids Research 2025cited by 5position: middledoi
Prediction of m6A and m5C at single-molecule resolution reveals a transcriptome-wide co-occurrence of RNA modifications
Nature Communications 2024cited by 108position: middledoi
Pathogenic proteotoxicity of cryptic splicing is alleviated by ubiquitination and ER-phagy
Science 2024cited by 24position: middledoi
Intrinsically disordered RNA-binding motifs cooperate to catalyze RNA folding and drive phase separation
Nucleic Acids Research 2024cited by 4position: middledoi
<i>Arabidopsis thaliana</i> GLYCINE RICH RNA‐BINDING PROTEIN 7 interaction with its iCLIP target <i>LHCB1.1</i> correlates with changes in RNA stability and circadian oscillation
The Plant Journal 2023cited by 39position: middledoi
RNA stability controlled by m6A methylation contributes to X-to-autosome dosage compensation in mammals
Nature Structural & Molecular Biology 2023cited by 34position: middledoi
High-throughput mutagenesis identifies mutations and RNA-binding proteins controlling CD19 splicing and CART-19 therapy resistance
Nature Communications 2022cited by 57position: middledoi
Deep and accurate detection of m6A RNA modifications using miCLIP2 and m6Aboost machine learning
Nucleic Acids Research 2021cited by 114position: lastdoi
High-throughput mutagenesis identifies mutations and RNA-binding proteins controlling <i>CD19</i> splicing and CART-19 therapy resistance
bioRxiv (Cold Spring Harbor Laboratory) 2021cited by 1position: middledoi
iCLIP data analysis: A complete pipeline from sequencing reads to RBP binding sites
Methods 2019cited by 84position: lastdoi
Decoding a cancer-relevant splicing decision in the RON proto-oncogene using high-throughput mutagenesis
Nature Communications 2018cited by 94position: lastdoi
Membrane-Associated RNA-Binding Proteins Orchestrate Organelle-Coupled Translation
Trends in Cell Biology 2018cited by 88position: lastdoi
Insights into the design and interpretation of iCLIP experiments
Genome biology 2017cited by 99position: middledoi
Interaction profiling of RNA-binding ubiquitin ligases reveals a link between posttranscriptional regulation and the ubiquitin system
Scientific Reports 2017cited by 20position: middledoi
Splicing repression allows the gradual emergence of new Alu-exons in primate evolution
eLife 2016cited by 82position: middledoi
The RNA-binding protein HuR is essential for the B cell antibody response
Nature Immunology 2015cited by 163position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

· 9 papers (2016–2025) · 6 papers (2018–2023)Mariela Cortés-López · New York Genome Center3 papers (2018–2022)Stefan Legewie · University of Stuttgart3 papers (2018–2022)Jernej Ule · King's College London3 papers (2015–2017)Laura Schulz · Institute of Molecular Biology3 papers (2018–2022)You Zhou · Beijing Institute of Technology3 papers (2021–2024) · 3 papers (2021–2023)Peter Hoch-Kraft · Johannes Gutenberg University Mainz2 papers (2021–2023)Yoseph Barash · California University of Pennsylvania2 papers (2021–2022)Michael Sattler · Technical University of Munich2 papers (2023–2024)Oliver Rausch · Mission Therapeutics (United Kingdom)2 papers (2021–2023)Claudia Paret · German Cancer Research Center2 papers (2021–2022)F.X. Reymond Sutandy · National Central University2 papers (2018–2021) · 2 papers (2018–2019)Dorothee Dormann · Johannes Gutenberg University Mainz2 papers (2024–2025)Mathieu Quesnel-Vallières · California University of Pennsylvania2 papers (2021–2022) · 2 papers (2021–2022)Tomaž Curk · European Molecular Biology Laboratory2 papers (2015–2017)Jan Attig · Roche (Switzerland)2 papers (2016–2017)